Cost–effectiveness of nanomedicine: estimating the real size of nano-costs
In this editorial, published in the journal Nanomedicine, Rita Bosetti and Stephen Jones (both Center for Outcomes Research; TX, USA) explore the importance of cost–effectiveness analyses to successful translation of nanodrugs from bench to bedside.
Please sign in or register for FREE
Sign in to The Evidence Base®
Did you know?
Your The Evidence Base™ account also gives you access to communities on regenerative medicine, real-world evidence and drug discovery. Find out more>>